Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy

NCT02262806 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

29

Enrollment

NIH

Sponsor class

Conditions

Diabetes
Lipodystrophy
Hyperlipidemia

Interventions

DRUG: Metreleptin

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)